CBIO:NASDAQ
Crescent Biopharma Inc
$13.75
arrow_upward
+1.33%(+0.18) 1D
Oct 7, 12:46:22 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CBIO...
Open
$13.47
High
$14.20
Low
$13.26
Mkt. cap
510.73M
Avg. vol.
463.73K
Volume
723.36K
52-wk high
$27.41
52-wk low
$8.72
EPS
-$7.41
Beta
1.27
Shares outstanding
37.14M
No. of employees
69
Open
$13.47
High
$14.20
Low
$13.26
Mkt. cap
510.73M
Avg. vol.
463.73K
Volume
723.36K
52-wk high
$27.41
52-wk low
$8.72
EPS
-$7.41
Beta
1.27
Shares outstanding
37.14M
No. of employees
69
News stories
From web sources and news partners
Stock Titan
·
20 hours ago
Six employees can buy Crescent shares for $13.94 each once their options vest.
Investing.com
·
1 day ago
Stifel reiterates Buy on Crescent Biopharma stock, $28 target
Investing.com
·
1 day ago
Crescent Biopharma stock rating upgraded to buy at H.C. Wainwright
Stock Titan
·
2 days ago
The FDA clears an application to test Crescent’s cancer treatment in people.
About Crescent Biopharma Inc
CEO-
Employees69
Founded2024
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitecrescentbiopharma.com